Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Richard K BoganNancy Foldvary-SchaeferRoman SkowronskiAbby ChenMichael J ThorpyPublished in: CNS drugs (2023)
ClinicalTrials.gov identifier NCT03030599 (25 January 2017).